Involvement of peripheral cannabinoid and opioid receptors in b-caryophyllene-induced antinociception

European Journal of Pain (United Kingdom)

Volumn 17, Issue 5, 2013, Pages 664-675

  Katsuyama, S ^a,b   Mizoguchi, H ^b   Kuwahata, H ^a   Komatsu, T ^a   Nagaoka, K ^b   Nakamura, H ^b   Bagetta, G ^c   Sakurada, T ^a   Sakurada, S ^b  

^a DAIICHI UNIVERSITY OF PHARMACY   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c University Center for Adaptive Disorders and Headache UCHAD   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 17 METHYLNALOXONE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANTISERUM; BETA ENDORPHIN; BETA FUNALTREXAMINE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CAPSAICIN; CARYOPHYLLENE; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; OPIATE RECEPTOR;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CURVE FITTING; DOSE RESPONSE; DRUG ANTAGONISM; KERATINOCYTE; LICKING; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CANNABINOIDS; ENDORPHINS; MICE; MORPHINE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NOCICEPTION; PAIN; PAIN MEASUREMENT; RECEPTOR, CANNABINOID, CB2; RECEPTORS, OPIOID; SESQUITERPENES;

EID: 84876449304     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2012.00242.x     Document Type: Article

References (47)

1. Agarwal, R.B., Rangari, V.D. (2003). Phytochemical investigation and evaluation of anti-inflammatory and anti-arthritic activities of essential oil of Strobilanthus ixiocephala Benth. Indian J Exp Biol 41, 890-894.
2. 2 receptors and the endocannabinoid system for the treatment of pain. Brain Res Rev 60, 255-266.
3. 2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons. Pain 138, 667-680.
4. Baricevic, D., Sosa, S., Della Loggia, R., Tubaro, A., Simonovska, B., Krasna, A., Zupancic, A. (2001). Topical anti-inflammatory activity of Salvia officinalis L. leaves: The relevance of ursolic acid. J Ethnopharmacol 75, 125-132.
5. Beltramo, M. (2009). Cannabinoid type 2 receptor as a target for chronic - pain. Mini Rev Med Chem 9, 11-25.
6. 2 receptor activation and PPARg pathway. Am J Pathol 178, 1153-1166.
7. 2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: Involvement of cytokine/chemokines and PMN. J Leukoc Biol 75, 453-459.
8. Di Marzo, V., Blumberg, P.M., Szallasi, A. (2002). Endovanilloid signaling in pain. Curr Opin Neurobiol 12, 372-379.
9. Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S.D., Leon, A. (1995). Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci U S A 92, 3376- 3380.
10. Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G., Casellas, P. (1995). Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232, 54-61.
11. Gamse, R., Molnar, A., Lembeck, F. (1979). Substance P release from spinal slices by capsaicin. Life Sci 25, 629-636.
12. Gertsch, J., Leonti, M., Radune, R.S., Racz, I., Chen, J.Z., Xie, X.Q., Altmann, K.H., Karsak, M., Zimmer, A. (2008). Betacaryophyllene is a dietary cannabinoid. Proc Natl Acad Sci U S A 105, 9099-9104.
13. Guan, Y., Johanek, L.M., Hartke, T.V., Shim, B., Tao, Y.X., Ringkanp, M., Meyer, R.A., Raja, S.N. (2008). Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury. Pain 138, 318- 329.
14. Haller, V.L., Stevens, D.L., Welch, S.P. (2008). Modulation of opioid via protection of anandamide degradation by fatty acid amide hydrolase. Eur J Pharmacol 600, 50-58.
15. Hama, A.T., Sagen, J. (2010). Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain. Neuropharmacology 58, 758-766.
16. Hendriks, H., Malingre, T., Battermann, S., Boss, R. (1975). Mono- and sesquiterpene hydrocarbons of essential oil of Cannabis sativa. Phytochemistry 14, 814-815.
17. Hohmann, A.G. (2002). Spinal and peripheral mechanisms of cannabinoid antinociception: Behavioral, neurophysiological and neuroanatomical perspectives. Chem Phys Lipids 121, 173- 190.
18. 2 receptors suppresses hyperalgesia evoked by intradermal capsaicin. J Pharmacol Exp Ther 308, 446-453.
19. Hughes, A., Macleod, A., Growcott, J., Thomas, I. (2002). Assessment of the reproducibility of intradermal administration as a model for inducing human pain. Pain 99, 323-331.
20. Hylden, J.L.K., Wilcox, G.L. (1980). Intrathecal morphine in mice: A new technique. Eur J Pharmacol 67, 313-316.
21. 2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci U S A 102, 3093-3098.
22. Katsuyama, S., Mizoguchi, H., Komatsu, T., Nagaoka, K., Sakurada, S., Sakurada, T. (2010). The cannabinoid 1 receptor antagonist AM251 produces nocifensive behavior via activation of ERK signaling pathway. Neuropharmacology 59, 534- 541.
23. Lan, R., Liu, Q., Fan, P., Lin, S., Fernando, S.R., McCallion, D., Pertwee, R., Makriyannis, A. (1999). Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42, 769-776.
24. Legault, J., Pichette, A. (2007). Potentiating effect of betacaryophyllene on anticancer activity of alpha-humulene, isocaryophyllene and paclitaxel. J Pharm Pharmacol 59, 1643- 1647.
25. Lewanowitsch, T., Irvine, R.J. (2002). Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal. Eur J Pharmacol 7, 61-67.
26. 2 cannabinoid receptor-mediated peripheral antinociception. Pain 93, 239-245.
27. 2 cannabinoid receptors. Chem Phys Lipids 121, 191- 200.
28. Martin, S., Padilla, E., Ocete, M.A., Galvez, J., Jimenez, J., Zarzuelo, A. (1993). Anti-inflammatory activity of the essential oil of Bupleurum fruticescens. Planta Med 59, 533-536.
29. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., Bonner, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561- 564.
30. Munro, S., Thomas, K.L., Abu-Shaar, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
31. Nackley, A.G., Suplita, II, R.L., Hohmann, A.G. (2003). A peripheral cannabinoid mechanism suppresses spinal Fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 117, 659-670.
32. Obara, I., Przewlocki, R., Przewlocka, B. (2004). Local peripheral effects of m-opioid receptor agonists in neuropathic pain in rats. Neurosci Lett 360, 85-89.
33. Pelissier, T., Pajot, J., Dallel, R. (2002). The orofacial capsaicin test in rats: Effects of different capsaicin concentrations and morphine. Pain 96, 81-87.
34. 2 cannabinoid receptors. Anesthesiology 99, 955-960.
35. 2 cannabinoid receptors of L759633, L759656, and AM630. Br J Pharmacol 126, 665-672.
36. Sakurada, S., Zadina, J.E., Kastin, A.J., Katsuyama, S., Fujimura, T., Murayama, K., Yuki, M., Ueda, H., Sakurada, T. (1999). Differential involvement of m-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception. Eur J Pharmacol 372, 25-30.
37. Sakurada, T., Katsumata, K., Tan-No, K., Sakurada, S., Kisara, K. (1992). The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacology 31, 1279- 1285.
38. Sakurada, T., Matsumura, T., Moriyama, T., Sakurada, C., Ueno, S., Sakurada, S. (2003). Differential effects of intraplantar capsazepine and ruthenium red on capsaicin-induced desensitization in mice. Pharmacol Biochem Behav 75, 115- 121.
39. Sakurada, T., Yogo, H., Katsumata, K., Tan-No, K., Sakurada, S., Kisara, K., Ohba, M. (1994). Differential antinociceptive effects of sendide, a NK1-receptor antagonist, and morphine in the capsaicin test. Brain Res 649, 319-322.
40. 9- tetrahydrocannabinol. Pharmacol Biochem Behav 60, 559- 566.
41. Sorkin, L.S., McAdoo, D.J. (1993). Amino acids and serotonin are released into the lumbar spinal cord of the anesthetized cat following intradermal capsaicin injections. Brain Res 607, 89-98.
42. Szallasi, A., Cortright, D.N., Blum, C.A., Eid, S.R. (2007). The vanilloid receptor TRPV1:10 years from channel cloning to antagonist proof-concept. Nat Rev 6, 357-372.
43. Takemori, A.E., Ho, B.Y., Naeseth, J.S., Portoghese, P.S. (1988). Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther 246, 255-258.
44. Tham, S.M., Angus, J.A., Tudor, E.M., Wright, C.E. (2005). Synergistic and additive interactions of the cannabinoid agonist CP55, 940 with m-opioid receptor and α2-adrenoceptor agonists in acute pain models. Br J Pharmacol 144, 875- 884.
45. Ueda, M., Kuraishi, Y., Satoh, M. (1993). Detection of capsaicinevoked release of glutamate from spinal dorsal horn slices of rat with on-line monitoring system. Neurosci Lett 155, 179-182.
46. Yesilyurt, O., Dogrul, A., Gul, H., Seyrek, M., Kusmez, O., Ozkan, Y., Yildiz, O. (2003). Topical cannabinoid enhances topical morphine antinociception. Pain 105, 303-308.
47. Zimmermann, M. (1983). Ethical guidelines for investigation of experimental pain in conscious animals. Pain 16, 109-110.